LPL expression in macrophages, adipocytes and cardiomyocytes has been proposed to affect cardiovascular disease, with a pro-atherogenic effect when expressed in macrophages, anti-atherogenic in adipocytes, and myopathy-promoting in cardiomyocytes [59–61]. This evidence concerns the gene LPL and cardiovascular disorder.